Table 3.
The correlation between patients’ clinical data with reproductive organ involvement
| Variable | Unadjusted * | Adjusted** | |||
|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | ||
| Clinical T stage | T2 (Ref) | 2.51(1.01-6.19) | 0.046 | 4.40 (1.06-18.13) | 0.040 |
| T3 | |||||
| Tumor location | Other (Ref) | 7.52 (2.89-19.57) | <0.001 | 16.24 (3.22-81.97) | <0.001 |
| Trigone/bladder neck | |||||
| Maximum tumor size | ≤5 (Ref) | 3.84 (1.54-9.52) | 0.004 | 6.07 (1.35-27.31) | 0.019 |
| >5 cm | |||||
| Concomitant CIS | No (Ref) | 3.02 (1.21-7.54) | 0.017 | 9.26 (1.92-44.59) | 0.005 |
| Yes | |||||
| Lymphovascular invasion | No (Ref) | 4.14 (1.59-10.76) | 0.004 | 15.51 (2.62-91.81) | 0.003 |
| Yes | |||||
| Hydronephrosis | No (Ref) | 6.32 (2.40-16.65) | <0.001 | 8.68 (1.92-39.16) | 0.005 |
| Yes | |||||
OR: Odds ratio; CI: Confidence interval; Ref: Reference; CIS: Carcinoma in situ;
*
Univariate logistic regression test;
**
Multivariate logistic regression test;
P<0.05 was considered statistically significant.